Rofo 2020; 192(06): 580-583
DOI: 10.1055/a-1084-4042
The Interesting Case
© Georg Thieme Verlag KG Stuttgart · New York

Can you trust the Prostate Imaging Reporting and Data System (PI-RADS) in special cases?

Birte Valentin
1  University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, Dusseldorf, Germany
,
Dirk Blondin
2  Elisabeth Hospital Rheydt, Department of Radiology, Vascular Radiology and Nuclear Medicine, Mönchengladbach, Germany
,
Tim Ullrich
1  University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, Dusseldorf, Germany
,
Christian Arsov
3  University Dusseldorf, Medical Faculty, Department of Urology, Dusseldorf, Germany
,
Maximilian Ackermann
4  University Dusseldorf, Medical Faculty, Department of Pathology, Dusseldorf, Germany
,
Gerald Antoch
1  University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, Dusseldorf, Germany
,
Lars Schimmöller
1  University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, Dusseldorf, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
16 January 2020 (online)

Introduction

Prostate cancer is the second most common cancer and the fifth most common cause of cancer-related death in men worldwide. MRI of the prostate has become an efficient method to detect prostate cancer. PI-RADS guidelines (Prostate Imaging – Reporting and Data System) have been established to standardize MRI of the prostate internationally. We report a case of a prostate lesion defined as likely to be benign on MRI according to PI-RADS version 2 and 2.1 (Assessment category: PI-RADS 2) which was later diagnosed as mucinous prostate adenocarcinoma, a rare variant of prostate adenocarcinoma (0.2 to 0.4 % of acinar adenocarcinoma).